UPDATE : Monday, September 16, 2019
상단여백
Amgen’s lipid-lowering Repatha beats Sanofi’s Praluent in Q2 sales
Amgen won the battle against Sanofi in sales of cholesterol-lowering PCSK9 ...
by Kim Yun-mi  |  2019-08-05 15:37
라인
SillaJen remains confident about Pexa-Vec’s value, despite trial failure
SillaJen said Pexa-Vec, an oncolytic viral drug, still had significant pote...
by Jeong Sae-im  |  2019-08-05 14:49
라인
Suspicions resurge over SillaJen execs’ stock selling before Pexa-Vec trial suspension
With the likely suspension of SillaJen’s trial on its major anticancer pipe...
by Jeong Sae-im  |  2019-08-05 11:26
라인
Helixmith unveils results for neuromuscular disease treatment
Helixmith has published a study that confirmed the efficacy of AV6-H’s, a g...
by Lee Han-soo  |  2019-08-02 17:52
라인
Japan’s 'whitelist’ removal to have minimal effect on biopharmaceutical sector
The local biopharmaceutical industry expects that Japan’s decision to remov...
by Lee Han-soo  |  2019-08-02 17:14
라인
‘MSD Korea playing tricks to maintain monitoring on salespersons’
MSD Korea’s labor and management are again in dispute over the so-called “s...
by Kim Yun-mi  |  2019-08-02 15:48
라인
Biotech shares tank amid SillaJen’s likely halt of Pexa-Vec trial
Local biotech shares went down altogether on Friday after SillaJen said it ...
by Jeong Sae-im  |  2019-08-02 15:45
라인
Conflict erupts between employees of Takeda, Shire during merger
Takeda Pharmaceutical Korea’s labor union said Takeda employees faced unfai...
by Kim Yun-mi  |  2019-08-02 14:23
라인
Researchers use ultrasonic wave to charge in-body medical devices
A local research team has succeeded in developing a technology that can cha...
by Lee Han-soo  |  2019-08-02 14:09
라인
Sillajen likely to scrap global P3 trials for Pexa-Vec
Sillajen is in danger of aborting its phase 3 clinical trial for Pexa-Vec (...
by Lee Han-soo  |  2019-08-02 10:29
라인
Childbirth continues to hit new lows in Korea
The number of births and marriages hit new lows in May, as Korea's chil...
by Lee Han-soo  |  2019-08-01 18:09
라인
KAIST-Hanyang University team presents new anticancer principle
Researchers at Korea Advanced Institute of Science & Technology (KAIST) and...
by Lee Han-soo  |  2019-08-01 17:30
라인
Eutilex pipelines are underrated: CEO
Eutilex CEO Kwon Byeong-se said he felt sorry for the recent fall of the co...
by Jeong Sae-im  |  2019-08-01 16:08
라인
‘Recurrent chronic lymphocytic leukemia needs various treatment options’
Chronic lymphocytic leukemia (CLL) progresses more slowly than acute blood ...
by Kim Yun-mi  |  2019-08-01 15:31
라인
Health ministry to reimburse Novartis’ Revolade treating severe aplastic anemia
Novartis Korea’s Revolade (ingredient: eltrombopag) will receive reimbursem...
by Lee Han-soo  |  2019-08-01 13:36
라인
‘NOAC treatment effective against liver disease-associated atrial fibrillation’
Researchers at Seoul National University Hospital have found that non-vitam...
by Lee Han-soo  |  2019-08-01 13:35
라인
New weight loss drug Qsymia wins local approval
The local drug regulator has approved a new obesity treatment, Qsymia Cap. ...
by Lee Hye-seon  |  2019-08-01 10:57
라인
‘Hanmi’s Carnitil improves cognitive function in patients’
Hanmi Pharmaceutical said that it has presented the phase 4 clinical trial ...
by Lee Han-soo  |  2019-07-31 17:05
라인
Hanall marks record sales in Q2
Hanall Biopharma said that it registered record-breaking sales and operatin...
by Lee Han-soo  |  2019-07-31 17:00
라인
[Column] Drug regulator needs adequate expertise to promote medical devices
In the healthcare sector, the medical device industry has the largest growt...
by Korea Biomedical Review  |  2019-07-31 16:59
여백
여백
여백
Back to Top